 Casey Greene
Concepts (385)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computational Biology | 29 | 2022 | 530 | 5.410 |
Why?
| | Gene Expression Profiling | 19 | 2023 | 1521 | 3.730 |
Why?
| | Machine Learning | 17 | 2023 | 318 | 3.510 |
Why?
| | Genomics | 17 | 2024 | 639 | 2.950 |
Why?
| | Software | 16 | 2023 | 536 | 2.720 |
Why?
| | Transcriptome | 18 | 2023 | 727 | 2.710 |
Why?
| | Information Dissemination | 6 | 2020 | 187 | 2.380 |
Why?
| | Gene Regulatory Networks | 9 | 2023 | 228 | 2.310 |
Why?
| | Neoplasms | 12 | 2022 | 2105 | 1.840 |
Why?
| | Epistasis, Genetic | 6 | 2023 | 67 | 1.790 |
Why?
| | Data Mining | 5 | 2018 | 100 | 1.690 |
Why?
| | Pseudomonas aeruginosa | 6 | 2022 | 298 | 1.690 |
Why?
| | Algorithms | 15 | 2023 | 1468 | 1.680 |
Why?
| | Single-Cell Analysis | 6 | 2021 | 188 | 1.650 |
Why?
| | Viral Vaccines | 2 | 2023 | 88 | 1.590 |
Why?
| | Rare Diseases | 2 | 2023 | 89 | 1.450 |
Why?
| | Databases, Genetic | 13 | 2022 | 206 | 1.420 |
Why?
| | Sequence Analysis, RNA | 6 | 2023 | 388 | 1.350 |
Why?
| | Gene Expression | 4 | 2023 | 1420 | 1.210 |
Why?
| | Research Personnel | 2 | 2020 | 151 | 1.190 |
Why?
| | Genome-Wide Association Study | 10 | 2021 | 1197 | 1.160 |
Why?
| | Biomedical Research | 4 | 2022 | 585 | 1.120 |
Why?
| | Ovarian Neoplasms | 5 | 2023 | 388 | 1.080 |
Why?
| | Peer Review, Research | 2 | 2022 | 34 | 0.970 |
Why?
| | Nonlinear Dynamics | 2 | 2023 | 83 | 0.960 |
Why?
| | Humans | 91 | 2024 | 114709 | 0.900 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2023 | 25 | 0.880 |
Why?
| | User-Computer Interface | 4 | 2023 | 141 | 0.810 |
Why?
| | Societies, Scientific | 1 | 2021 | 47 | 0.760 |
Why?
| | Metadata | 1 | 2020 | 8 | 0.730 |
Why?
| | Neurofibromin 1 | 2 | 2019 | 22 | 0.730 |
Why?
| | Data Compression | 1 | 2020 | 5 | 0.710 |
Why?
| | Guidelines as Topic | 1 | 2022 | 244 | 0.690 |
Why?
| | Precision Medicine | 5 | 2024 | 338 | 0.680 |
Why?
| | Language | 1 | 2022 | 258 | 0.660 |
Why?
| | Computer Security | 1 | 2019 | 18 | 0.660 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2021 | 440 | 0.660 |
Why?
| | Genetic Association Studies | 3 | 2016 | 344 | 0.650 |
Why?
| | Confidentiality | 1 | 2019 | 67 | 0.640 |
Why?
| | Pharmaceutical Preparations | 1 | 2020 | 168 | 0.620 |
Why?
| | Scholarly Communication | 1 | 2018 | 2 | 0.610 |
Why?
| | ras Proteins | 2 | 2019 | 138 | 0.610 |
Why?
| | Glioblastoma | 2 | 2019 | 253 | 0.610 |
Why?
| | Databases, Bibliographic | 1 | 2018 | 29 | 0.610 |
Why?
| | Access to Information | 1 | 2018 | 47 | 0.580 |
Why?
| | Biomedical Technology | 1 | 2018 | 40 | 0.580 |
Why?
| | Disease | 3 | 2018 | 85 | 0.570 |
Why?
| | Gene Silencing | 2 | 2018 | 172 | 0.570 |
Why?
| | Models, Biological | 3 | 2020 | 1630 | 0.560 |
Why?
| | alpha-Synuclein | 1 | 2017 | 21 | 0.560 |
Why?
| | Genome, Human | 6 | 2018 | 351 | 0.550 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2016 | 129 | 0.540 |
Why?
| | Parasites | 1 | 2017 | 37 | 0.540 |
Why?
| | Systems Biology | 3 | 2018 | 56 | 0.530 |
Why?
| | MicroRNAs | 1 | 2022 | 601 | 0.530 |
Why?
| | Models, Genetic | 5 | 2019 | 565 | 0.530 |
Why?
| | Workflow | 1 | 2017 | 135 | 0.520 |
Why?
| | Gene Ontology | 5 | 2020 | 45 | 0.520 |
Why?
| | Bacterial Proteins | 2 | 2020 | 739 | 0.510 |
Why?
| | Neurodegenerative Diseases | 1 | 2017 | 91 | 0.500 |
Why?
| | Research | 1 | 2018 | 393 | 0.500 |
Why?
| | Tumor Microenvironment | 4 | 2023 | 433 | 0.500 |
Why?
| | Computer Simulation | 6 | 2019 | 878 | 0.500 |
Why?
| | Quantitative Trait, Heritable | 1 | 2016 | 117 | 0.500 |
Why?
| | Protein Interaction Maps | 1 | 2015 | 34 | 0.490 |
Why?
| | Internet | 5 | 2023 | 595 | 0.470 |
Why?
| | Bayes Theorem | 5 | 2018 | 331 | 0.450 |
Why?
| | Models, Theoretical | 1 | 2017 | 516 | 0.440 |
Why?
| | Unsupervised Machine Learning | 3 | 2019 | 9 | 0.440 |
Why?
| | RNA, Untranslated | 1 | 2014 | 113 | 0.410 |
Why?
| | Microbiota | 2 | 2017 | 648 | 0.400 |
Why?
| | Pandemics | 5 | 2023 | 1319 | 0.390 |
Why?
| | Drosophila melanogaster | 5 | 2019 | 191 | 0.390 |
Why?
| | Signal Transduction | 8 | 2020 | 4521 | 0.390 |
Why?
| | Probability | 2 | 2022 | 291 | 0.380 |
Why?
| | Databases, Factual | 2 | 2018 | 1126 | 0.370 |
Why?
| | Embryonic Development | 3 | 2020 | 117 | 0.340 |
Why?
| | Terminology as Topic | 3 | 2022 | 187 | 0.340 |
Why?
| | Molecular Sequence Annotation | 5 | 2023 | 81 | 0.340 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2010 | 61 | 0.330 |
Why?
| | Scleroderma, Systemic | 3 | 2017 | 96 | 0.320 |
Why?
| | Supervised Machine Learning | 2 | 2020 | 11 | 0.320 |
Why?
| | Genome | 2 | 2019 | 272 | 0.310 |
Why?
| | Polymorphism, Single Nucleotide | 7 | 2021 | 1892 | 0.300 |
Why?
| | Artificial Intelligence | 3 | 2020 | 145 | 0.300 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2021 | 706 | 0.290 |
Why?
| | Betacoronavirus | 2 | 2020 | 252 | 0.290 |
Why?
| | Proteomics | 4 | 2021 | 843 | 0.280 |
Why?
| | Drosophila Proteins | 2 | 2019 | 163 | 0.270 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2021 | 212 | 0.260 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 340 | 0.250 |
Why?
| | Data Interpretation, Statistical | 2 | 2018 | 322 | 0.250 |
Why?
| | Coronavirus Infections | 2 | 2020 | 332 | 0.250 |
Why?
| | Reproducibility of Results | 6 | 2021 | 2762 | 0.250 |
Why?
| | Publications | 2 | 2022 | 37 | 0.240 |
Why?
| | Breast Neoplasms | 2 | 2015 | 1868 | 0.230 |
Why?
| | Genetic Predisposition to Disease | 5 | 2021 | 2099 | 0.230 |
Why?
| | Cell Line, Tumor | 4 | 2019 | 2725 | 0.230 |
Why?
| | Causality | 1 | 2023 | 104 | 0.220 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2019 | 196 | 0.210 |
Why?
| | Vaccines, Subunit | 1 | 2023 | 42 | 0.210 |
Why?
| | Female | 17 | 2023 | 59483 | 0.210 |
Why?
| | Sample Size | 1 | 2022 | 114 | 0.200 |
Why?
| | Mushroom Bodies | 2 | 2019 | 6 | 0.200 |
Why?
| | Hedgehog Proteins | 2 | 2021 | 173 | 0.200 |
Why?
| | Electronic Health Records | 3 | 2018 | 801 | 0.200 |
Why?
| | Pancreatic Neoplasms | 2 | 2021 | 732 | 0.200 |
Why?
| | Cooperative Behavior | 2 | 2021 | 381 | 0.190 |
Why?
| | Alzheimer Disease | 2 | 2017 | 436 | 0.190 |
Why?
| | High-Throughput Screening Assays | 2 | 2014 | 123 | 0.190 |
Why?
| | Quality Control | 1 | 2021 | 144 | 0.190 |
Why?
| | Fibrosis | 2 | 2021 | 453 | 0.190 |
Why?
| | ADAM10 Protein | 1 | 2021 | 28 | 0.180 |
Why?
| | Animals | 16 | 2023 | 31761 | 0.180 |
Why?
| | Bone Development | 1 | 2021 | 47 | 0.180 |
Why?
| | Gamma Rays | 1 | 2021 | 48 | 0.180 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2020 | 1147 | 0.180 |
Why?
| | Linear Models | 1 | 2023 | 770 | 0.180 |
Why?
| | Cystadenoma, Serous | 1 | 2020 | 18 | 0.180 |
Why?
| | Medical Informatics | 1 | 2021 | 92 | 0.180 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2021 | 73 | 0.180 |
Why?
| | Privacy | 1 | 2020 | 28 | 0.180 |
Why?
| | Organ Specificity | 3 | 2017 | 268 | 0.180 |
Why?
| | Bone Diseases | 1 | 2021 | 57 | 0.180 |
Why?
| | Hemerythrin | 1 | 2020 | 1 | 0.180 |
Why?
| | Phenotype | 4 | 2021 | 2811 | 0.170 |
Why?
| | Cluster Analysis | 2 | 2019 | 460 | 0.170 |
Why?
| | Histone Code | 1 | 2020 | 28 | 0.170 |
Why?
| | Clinical Laboratory Techniques | 1 | 2020 | 87 | 0.170 |
Why?
| | Radiation Injuries | 1 | 2021 | 128 | 0.170 |
Why?
| | Systems Integration | 2 | 2017 | 37 | 0.170 |
Why?
| | Neurofibromatosis 1 | 1 | 2020 | 36 | 0.170 |
Why?
| | Radiosurgery | 1 | 2022 | 302 | 0.170 |
Why?
| | Biofilms | 2 | 2019 | 223 | 0.170 |
Why?
| | Cerebellar Neoplasms | 1 | 2021 | 130 | 0.170 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2021 | 168 | 0.170 |
Why?
| | Papillomavirus Infections | 1 | 2022 | 262 | 0.170 |
Why?
| | Genetic Fitness | 1 | 2020 | 55 | 0.160 |
Why?
| | Hypertension | 2 | 2019 | 1059 | 0.160 |
Why?
| | Exons | 1 | 2020 | 303 | 0.160 |
Why?
| | Medulloblastoma | 1 | 2021 | 172 | 0.160 |
Why?
| | Gene Expression Regulation | 3 | 2018 | 2321 | 0.160 |
Why?
| | DNA Repair | 2 | 2011 | 186 | 0.160 |
Why?
| | Cell Hypoxia | 1 | 2020 | 220 | 0.160 |
Why?
| | Base Sequence | 1 | 2022 | 2118 | 0.160 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2019 | 447 | 0.160 |
Why?
| | Computer Communication Networks | 1 | 2018 | 32 | 0.160 |
Why?
| | Alternative Splicing | 1 | 2020 | 188 | 0.160 |
Why?
| | Mutation | 4 | 2022 | 3349 | 0.160 |
Why?
| | Proteins | 2 | 2016 | 912 | 0.160 |
Why?
| | Multiple Myeloma | 1 | 2019 | 93 | 0.150 |
Why?
| | Pseudomonas fluorescens | 1 | 2018 | 3 | 0.150 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 436 | 0.150 |
Why?
| | Recombinational DNA Repair | 1 | 2018 | 9 | 0.150 |
Why?
| | Atlases as Topic | 1 | 2018 | 9 | 0.150 |
Why?
| | Writing | 1 | 2019 | 83 | 0.150 |
Why?
| | Bone and Bones | 1 | 2021 | 278 | 0.150 |
Why?
| | Cyclic GMP | 1 | 2018 | 78 | 0.150 |
Why?
| | Pennsylvania | 1 | 2018 | 94 | 0.150 |
Why?
| | Central Nervous System Neoplasms | 1 | 2019 | 126 | 0.150 |
Why?
| | Immunity, Cellular | 1 | 2019 | 248 | 0.150 |
Why?
| | Glomerulonephritis | 1 | 2018 | 45 | 0.150 |
Why?
| | False Positive Reactions | 1 | 2018 | 108 | 0.150 |
Why?
| | Publishing | 1 | 2019 | 125 | 0.150 |
Why?
| | Bibliometrics | 1 | 2018 | 44 | 0.150 |
Why?
| | Public Sector | 1 | 2017 | 17 | 0.150 |
Why?
| | Phosphoproteins | 1 | 2019 | 299 | 0.150 |
Why?
| | Natural Language Processing | 1 | 2018 | 71 | 0.150 |
Why?
| | Starvation | 1 | 2017 | 21 | 0.140 |
Why?
| | Mice | 10 | 2023 | 14916 | 0.140 |
Why?
| | Trans-Activators | 1 | 2020 | 368 | 0.140 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 385 | 0.140 |
Why?
| | Drug Design | 1 | 2018 | 151 | 0.140 |
Why?
| | Metabolic Networks and Pathways | 1 | 2018 | 168 | 0.140 |
Why?
| | Information Storage and Retrieval | 1 | 2017 | 107 | 0.140 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 258 | 0.130 |
Why?
| | Data Collection | 1 | 2019 | 622 | 0.130 |
Why?
| | Cystadenocarcinoma, Serous | 1 | 2016 | 44 | 0.130 |
Why?
| | Phylogeny | 1 | 2020 | 794 | 0.130 |
Why?
| | Amygdala | 1 | 2017 | 170 | 0.130 |
Why?
| | Genome, Microbial | 1 | 2016 | 7 | 0.130 |
Why?
| | Memory | 1 | 2017 | 209 | 0.130 |
Why?
| | Blood Pressure | 2 | 2019 | 1530 | 0.130 |
Why?
| | Microbial Consortia | 1 | 2016 | 18 | 0.130 |
Why?
| | Antihypertensive Agents | 1 | 2019 | 429 | 0.130 |
Why?
| | Drug Repositioning | 1 | 2015 | 13 | 0.130 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2018 | 285 | 0.130 |
Why?
| | Research Design | 1 | 2021 | 931 | 0.130 |
Why?
| | Liver Cirrhosis, Biliary | 1 | 2015 | 18 | 0.130 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2018 | 743 | 0.130 |
Why?
| | Structure-Activity Relationship | 1 | 2016 | 503 | 0.130 |
Why?
| | Toxicology | 1 | 2015 | 36 | 0.120 |
Why?
| | Social Behavior | 1 | 2017 | 268 | 0.120 |
Why?
| | Search Engine | 1 | 2015 | 9 | 0.120 |
Why?
| | Prognosis | 3 | 2021 | 3334 | 0.120 |
Why?
| | Knowledge Bases | 1 | 2015 | 17 | 0.120 |
Why?
| | Membrane Proteins | 1 | 2021 | 1022 | 0.120 |
Why?
| | Circadian Rhythm | 1 | 2017 | 355 | 0.120 |
Why?
| | Metabolome | 1 | 2017 | 283 | 0.120 |
Why?
| | Decision Support Techniques | 1 | 2018 | 351 | 0.120 |
Why?
| | Pharmacogenetics | 1 | 2015 | 149 | 0.120 |
Why?
| | Proteome | 1 | 2017 | 339 | 0.120 |
Why?
| | Macrophages | 1 | 2021 | 1261 | 0.120 |
Why?
| | Hospital Mortality | 1 | 2018 | 776 | 0.110 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2019 | 1214 | 0.110 |
Why?
| | Intensive Care Units | 1 | 2018 | 618 | 0.110 |
Why?
| | Genes | 3 | 2013 | 224 | 0.110 |
Why?
| | Length of Stay | 1 | 2018 | 949 | 0.110 |
Why?
| | Cystic Fibrosis | 1 | 2022 | 955 | 0.110 |
Why?
| | Biological Phenomena | 1 | 2013 | 4 | 0.110 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2015 | 235 | 0.110 |
Why?
| | Podocytes | 1 | 2013 | 44 | 0.110 |
Why?
| | Sensitivity and Specificity | 1 | 2017 | 1690 | 0.100 |
Why?
| | Receptors, Estrogen | 1 | 2015 | 372 | 0.100 |
Why?
| | Brain Neoplasms | 1 | 2019 | 984 | 0.100 |
Why?
| | Cell Lineage | 1 | 2013 | 310 | 0.100 |
Why?
| | Survival Analysis | 1 | 2015 | 1218 | 0.100 |
Why?
| | Decision Making | 1 | 2018 | 781 | 0.100 |
Why?
| | Cell Line | 2 | 2017 | 2639 | 0.100 |
Why?
| | Polymorphism, Genetic | 2 | 2017 | 612 | 0.100 |
Why?
| | Pediatrics | 1 | 2019 | 983 | 0.090 |
Why?
| | Parkinson Disease | 1 | 2015 | 323 | 0.090 |
Why?
| | Delivery of Health Care | 1 | 2018 | 833 | 0.090 |
Why?
| | Male | 12 | 2021 | 55554 | 0.090 |
Why?
| | Bias | 1 | 2012 | 180 | 0.090 |
Why?
| | Knowledge | 1 | 2010 | 49 | 0.090 |
Why?
| | Multifactor Dimensionality Reduction | 1 | 2010 | 2 | 0.090 |
Why?
| | Models, Statistical | 3 | 2020 | 604 | 0.090 |
Why?
| | RNA | 3 | 2022 | 810 | 0.090 |
Why?
| | Transcription Factors | 1 | 2017 | 1528 | 0.090 |
Why?
| | Kidney Diseases | 1 | 2013 | 350 | 0.090 |
Why?
| | Child | 4 | 2021 | 18348 | 0.080 |
Why?
| | Memory, Long-Term | 2 | 2019 | 11 | 0.080 |
Why?
| | Rats | 3 | 2013 | 4943 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2017 | 1183 | 0.080 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 4621 | 0.080 |
Why?
| | Geography | 1 | 2009 | 180 | 0.080 |
Why?
| | Biopsy | 3 | 2018 | 1040 | 0.080 |
Why?
| | United States | 2 | 2021 | 12175 | 0.080 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2013 | 486 | 0.080 |
Why?
| | Gene Frequency | 1 | 2009 | 481 | 0.070 |
Why?
| | Neoplasm Grading | 2 | 2020 | 242 | 0.070 |
Why?
| | Cells, Cultured | 1 | 2015 | 3890 | 0.070 |
Why?
| | Multifactorial Inheritance | 1 | 2008 | 125 | 0.070 |
Why?
| | Adult | 5 | 2020 | 30542 | 0.070 |
Why?
| | Alleles | 1 | 2009 | 791 | 0.070 |
Why?
| | Cytokines | 2 | 2018 | 1843 | 0.070 |
Why?
| | Terminal Repeat Sequences | 1 | 2006 | 15 | 0.070 |
Why?
| | Retroelements | 1 | 2006 | 39 | 0.060 |
Why?
| | Treatment Outcome | 1 | 2019 | 9089 | 0.060 |
Why?
| | Bone Density | 2 | 2021 | 432 | 0.060 |
Why?
| | Pilot Projects | 2 | 2022 | 1370 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2009 | 3004 | 0.060 |
Why?
| | Sequence Analysis, DNA | 2 | 2020 | 728 | 0.060 |
Why?
| | Biological Specimen Banks | 1 | 2024 | 94 | 0.050 |
Why?
| | Aged | 5 | 2020 | 19078 | 0.050 |
Why?
| | Microarray Analysis | 1 | 2023 | 119 | 0.050 |
Why?
| | Smoking | 1 | 2010 | 1384 | 0.050 |
Why?
| | Middle Aged | 6 | 2020 | 26747 | 0.050 |
Why?
| | Budgets | 1 | 2021 | 14 | 0.050 |
Why?
| | Interdisciplinary Research | 1 | 2021 | 25 | 0.050 |
Why?
| | Gene Library | 1 | 2021 | 114 | 0.050 |
Why?
| | Ephrin-B2 | 1 | 2021 | 36 | 0.050 |
Why?
| | Young Adult | 3 | 2021 | 10461 | 0.050 |
Why?
| | Neoadjuvant Therapy | 1 | 2022 | 305 | 0.050 |
Why?
| | Gene Editing | 1 | 2021 | 57 | 0.040 |
Why?
| | Neurofibroma | 1 | 2020 | 3 | 0.040 |
Why?
| | Neurofibroma, Plexiform | 1 | 2020 | 5 | 0.040 |
Why?
| | Nerve Sheath Neoplasms | 1 | 2020 | 7 | 0.040 |
Why?
| | DNA, Mitochondrial | 1 | 2021 | 182 | 0.040 |
Why?
| | Osteoblasts | 1 | 2021 | 106 | 0.040 |
Why?
| | Data Accuracy | 1 | 2020 | 48 | 0.040 |
Why?
| | Genetic Markers | 1 | 2021 | 321 | 0.040 |
Why?
| | Asymptomatic Diseases | 1 | 2020 | 75 | 0.040 |
Why?
| | Antigens, CD20 | 1 | 2019 | 28 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2021 | 489 | 0.040 |
Why?
| | Candida albicans | 1 | 2019 | 50 | 0.040 |
Why?
| | Genome, Fungal | 1 | 2019 | 28 | 0.040 |
Why?
| | Neoplasm, Residual | 1 | 2020 | 104 | 0.040 |
Why?
| | Peripheral Nerves | 1 | 2020 | 64 | 0.040 |
Why?
| | Manuscripts, Medical as Topic | 1 | 2019 | 4 | 0.040 |
Why?
| | Mentoring | 1 | 2021 | 101 | 0.040 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 114 | 0.040 |
Why?
| | Reward | 1 | 2021 | 211 | 0.040 |
Why?
| | Microglia | 1 | 2021 | 202 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2021 | 854 | 0.040 |
Why?
| | Locomotion | 1 | 2019 | 80 | 0.040 |
Why?
| | Rhabdomyosarcoma | 1 | 2019 | 55 | 0.040 |
Why?
| | Genome, Bacterial | 1 | 2019 | 106 | 0.040 |
Why?
| | Osteosarcoma | 1 | 2019 | 67 | 0.040 |
Why?
| | Osteogenesis | 1 | 2021 | 183 | 0.040 |
Why?
| | Sarcoma, Ewing | 1 | 2019 | 65 | 0.040 |
Why?
| | Quantitative Trait Loci | 1 | 2021 | 307 | 0.040 |
Why?
| | Neuroblastoma | 1 | 2019 | 132 | 0.040 |
Why?
| | Wilms Tumor | 1 | 2019 | 69 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2019 | 285 | 0.040 |
Why?
| | Genes, Neoplasm | 1 | 2018 | 20 | 0.040 |
Why?
| | Mobile Applications | 1 | 2020 | 139 | 0.040 |
Why?
| | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2018 | 20 | 0.040 |
Why?
| | Two-Hybrid System Techniques | 1 | 2018 | 52 | 0.040 |
Why?
| | Monocytes | 1 | 2021 | 503 | 0.040 |
Why?
| | Loss of Heterozygosity | 1 | 2018 | 40 | 0.040 |
Why?
| | Nephrotic Syndrome | 1 | 2018 | 24 | 0.040 |
Why?
| | Pentose Phosphate Pathway | 1 | 2018 | 48 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2019 | 276 | 0.040 |
Why?
| | RNA-Binding Proteins | 1 | 2021 | 344 | 0.040 |
Why?
| | Protein Processing, Post-Translational | 1 | 2020 | 399 | 0.040 |
Why?
| | Acid Phosphatase | 1 | 2017 | 17 | 0.040 |
Why?
| | Mouth | 1 | 2017 | 69 | 0.040 |
Why?
| | Kidney Glomerulus | 1 | 2018 | 100 | 0.040 |
Why?
| | Patient Care Planning | 1 | 2018 | 139 | 0.040 |
Why?
| | Kidney Tubules | 1 | 2018 | 107 | 0.040 |
Why?
| | Motivation | 1 | 2021 | 494 | 0.040 |
Why?
| | Isoenzymes | 1 | 2018 | 285 | 0.040 |
Why?
| | Chromatin | 1 | 2021 | 428 | 0.040 |
Why?
| | GTPase-Activating Proteins | 1 | 2017 | 71 | 0.040 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2017 | 81 | 0.040 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2017 | 63 | 0.040 |
Why?
| | Wnt Proteins | 1 | 2018 | 135 | 0.040 |
Why?
| | Survival Rate | 1 | 2021 | 1642 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 936 | 0.030 |
Why?
| | Cell Movement | 1 | 2021 | 867 | 0.030 |
Why?
| | Databases, Protein | 1 | 2016 | 59 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 2021 | 592 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2021 | 1133 | 0.030 |
Why?
| | Saliva | 1 | 2017 | 189 | 0.030 |
Why?
| | Proof of Concept Study | 1 | 2016 | 44 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2018 | 330 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2021 | 689 | 0.030 |
Why?
| | Risk Factors | 1 | 2009 | 8625 | 0.030 |
Why?
| | Genetic Loci | 1 | 2017 | 263 | 0.030 |
Why?
| | Biopsy, Fine-Needle | 1 | 2016 | 64 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2019 | 633 | 0.030 |
Why?
| | Tumor Suppressor Proteins | 1 | 2018 | 282 | 0.030 |
Why?
| | Hydrocortisone | 1 | 2017 | 269 | 0.030 |
Why?
| | Blood Proteins | 1 | 2017 | 232 | 0.030 |
Why?
| | DNA Damage | 1 | 2018 | 357 | 0.030 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2018 | 221 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2018 | 449 | 0.030 |
Why?
| | Health Status | 1 | 2020 | 723 | 0.030 |
Why?
| | Oxygen | 1 | 2020 | 853 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 934 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 1843 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2021 | 1316 | 0.030 |
Why?
| | Esophagus | 1 | 2017 | 226 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 2017 | 493 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2016 | 561 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4085 | 0.030 |
Why?
| | Heart Rate | 1 | 2017 | 704 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2019 | 799 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2016 | 528 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 795 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2381 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2021 | 2196 | 0.030 |
Why?
| | Regression Analysis | 1 | 2015 | 946 | 0.030 |
Why?
| | Support Vector Machine | 1 | 2013 | 34 | 0.030 |
Why?
| | Adolescent | 2 | 2021 | 17806 | 0.030 |
Why?
| | Organogenesis | 1 | 2013 | 54 | 0.030 |
Why?
| | Skin | 1 | 2017 | 659 | 0.030 |
Why?
| | Embryo, Nonmammalian | 1 | 2013 | 173 | 0.030 |
Why?
| | Nanotechnology | 1 | 2013 | 113 | 0.030 |
Why?
| | Computer Graphics | 1 | 2012 | 41 | 0.030 |
Why?
| | Risk | 1 | 2015 | 815 | 0.020 |
Why?
| | Apoptosis | 1 | 2021 | 2369 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 4710 | 0.020 |
Why?
| | Drug Interactions | 1 | 2013 | 340 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2015 | 435 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2018 | 2557 | 0.020 |
Why?
| | Genetic Variation | 1 | 2015 | 876 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 4406 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 3542 | 0.020 |
Why?
| | Caenorhabditis elegans | 1 | 2013 | 269 | 0.020 |
Why?
| | Zebrafish Proteins | 1 | 2012 | 246 | 0.020 |
Why?
| | Zebrafish | 1 | 2013 | 411 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2012 | 367 | 0.020 |
Why?
| | Curriculum | 1 | 2015 | 824 | 0.020 |
Why?
| | Prostatic Neoplasms | 1 | 2015 | 925 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 6122 | 0.020 |
Why?
| | Child, Preschool | 1 | 2021 | 9077 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2017 | 6346 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2013 | 1699 | 0.020 |
Why?
| | Lung | 1 | 2017 | 3546 | 0.010 |
Why?
| | Inflammation | 1 | 2015 | 2481 | 0.010 |
Why?
| | Lung Neoplasms | 1 | 2015 | 2199 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2018 | 12511 | 0.010 |
Why?
|
|
Greene's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|